RPG LIFE SCIENCES
|
RPG LIFE SCIENCES Last 5 Year Balance Sheet History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity - Authorised | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity - Issued | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Paid Up | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹8.00 | ₹8.00 | ₹8.00 | ₹8.00 | ₹8.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹294 Cr | ₹243 Cr | ₹203 Cr | ₹163 Cr | ₹147 Cr |
Securities Premium | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr |
Capital Reserves | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr | ₹0.05 Cr |
Profit & Loss Account Balance | ₹251 Cr | ₹199 Cr | ₹160 Cr | ₹120 Cr | ₹104 Cr |
General Reserves | ₹8.63 Cr | ₹8.63 Cr | ₹8.63 Cr | ₹8.63 Cr | ₹8.63 Cr |
Other Reserves | - | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹294 Cr | ₹243 Cr | ₹203 Cr | ₹163 Cr | ₹147 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹308 Cr | ₹256 Cr | ₹216 Cr | ₹177 Cr | ₹161 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | ₹0.01 Cr | ₹0.08 Cr | ₹0.22 Cr | ₹4.63 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | ₹4.28 Cr | ₹4.25 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | ₹0.01 Cr | ₹0.08 Cr | ₹-4.06 Cr | ₹0.38 Cr |
Unsecured Loans | - | ₹0.29 Cr | ₹0.66 Cr | ₹1.30 Cr | ₹1.95 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | ₹0.29 Cr | ₹0.66 Cr | ₹1.30 Cr | ₹1.95 Cr |
Deferred Tax Assets / Liabilities | ₹1.97 Cr | ₹2.26 Cr | ₹-0.06 Cr | ₹-4.60 Cr | ₹-6.18 Cr |
Deferred Tax Assets | ₹4.73 Cr | ₹5.72 Cr | ₹9.08 Cr | ₹14 Cr | ₹19 Cr |
Deferred Tax Liability | ₹6.70 Cr | ₹7.98 Cr | ₹9.02 Cr | ₹9.85 Cr | ₹13 Cr |
Other Long Term Liabilities | ₹3.02 Cr | ₹3.13 Cr | ₹3.38 Cr | ₹3.33 Cr | ₹2.99 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹3.98 Cr | ₹3.04 Cr | ₹3.13 Cr | ₹8.50 Cr | ₹6.19 Cr |
Total Non-Current Liabilities | ₹8.97 Cr | ₹8.73 Cr | ₹7.19 Cr | ₹8.75 Cr | ₹9.58 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹65 Cr | ₹46 Cr | ₹47 Cr | ₹44 Cr | ₹25 Cr |
Sundry Creditors | ₹65 Cr | ₹46 Cr | ₹47 Cr | ₹44 Cr | ₹25 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹26 Cr | ₹20 Cr | ₹18 Cr | ₹20 Cr | ₹13 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.79 Cr | ₹2.46 Cr | ₹3.89 Cr | ₹2.72 Cr | ₹2.93 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | ₹0.64 Cr | ₹0.68 Cr |
Other Liabilities | ₹24 Cr | ₹17 Cr | ₹14 Cr | ₹17 Cr | ₹9.71 Cr |
Short Term Borrowings | - | ₹0.21 Cr | ₹0.52 Cr | ₹5.12 Cr | ₹29 Cr |
Secured ST Loans repayable on Demands | - | ₹0.21 Cr | ₹0.18 Cr | ₹1.86 Cr | ₹9.04 Cr |
Working Capital Loans- Sec | - | ₹0.21 Cr | ₹0.18 Cr | ₹1.86 Cr | ₹9.04 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | ₹-0.21 Cr | ₹0.16 Cr | ₹1.40 Cr | ₹11 Cr |
Short Term Provisions | ₹12 Cr | ₹15 Cr | ₹14 Cr | ₹13 Cr | ₹10 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | - | ₹0.38 Cr | - | - | - |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹12 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹10 Cr |
Total Current Liabilities | ₹103 Cr | ₹80 Cr | ₹80 Cr | ₹83 Cr | ₹78 Cr |
Total Liabilities | ₹419 Cr | ₹345 Cr | ₹303 Cr | ₹268 Cr | ₹248 Cr |
ASSETS | |||||
Gross Block | ₹220 Cr | ₹186 Cr | ₹180 Cr | ₹174 Cr | ₹163 Cr |
Less: Accumulated Depreciation | ₹96 Cr | ₹83 Cr | ₹67 Cr | ₹51 Cr | ₹35 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹124 Cr | ₹104 Cr | ₹113 Cr | ₹123 Cr | ₹128 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹15 Cr | ₹25 Cr | ₹9.44 Cr | ₹7.28 Cr | ₹10 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹5.60 Cr | ₹2.93 Cr | ₹2.41 Cr | ₹9.26 Cr | ₹6.00 Cr |
Other Non Current Assets | - | - | - | - | - |
Total Non-Current Assets | ₹155 Cr | ₹138 Cr | ₹127 Cr | ₹142 Cr | ₹151 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹58 Cr | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | ₹58 Cr | - | - | - | - |
Inventories | ₹95 Cr | ₹83 Cr | ₹58 Cr | ₹47 Cr | ₹41 Cr |
Raw Materials | ₹16 Cr | ₹12 Cr | ₹13 Cr | ₹7.33 Cr | ₹8.02 Cr |
Work-in Progress | ₹18 Cr | ₹17 Cr | ₹10 Cr | ₹9.39 Cr | ₹7.30 Cr |
Finished Goods | ₹28 Cr | ₹29 Cr | ₹21 Cr | ₹13 Cr | ₹12 Cr |
Packing Materials | ₹3.55 Cr | ₹2.85 Cr | ₹2.35 Cr | ₹1.64 Cr | ₹1.54 Cr |
Stores Ā and Spare | ₹1.26 Cr | ₹1.23 Cr | ₹1.17 Cr | ₹1.13 Cr | ₹0.95 Cr |
Other Inventory | ₹29 Cr | ₹20 Cr | ₹11 Cr | ₹15 Cr | ₹11 Cr |
Sundry Debtors | ₹37 Cr | ₹33 Cr | ₹57 Cr | ₹63 Cr | ₹39 Cr |
Debtors more than Six months | ₹2.15 Cr | ₹1.88 Cr | ₹1.73 Cr | - | - |
Debtors Others | ₹37 Cr | ₹32 Cr | ₹57 Cr | ₹64 Cr | ₹40 Cr |
Cash and Bank | ₹57 Cr | ₹70 Cr | ₹41 Cr | ₹1.11 Cr | ₹0.77 Cr |
Cash in hand | ₹0.02 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.03 Cr | ₹0.02 Cr |
Balances at Bank | ₹57 Cr | ₹70 Cr | ₹41 Cr | ₹1.08 Cr | ₹0.75 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹5.41 Cr | ₹6.64 Cr | ₹8.71 Cr | ₹8.22 Cr | ₹6.93 Cr |
Interest accrued on Investments | ₹0.56 Cr | ₹0.60 Cr | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹3.95 Cr | ₹2.38 Cr | ₹4.28 Cr | ₹4.63 Cr | ₹3.45 Cr |
Other current_assets | ₹0.90 Cr | ₹3.66 Cr | ₹4.43 Cr | ₹3.59 Cr | ₹3.48 Cr |
Short Term Loans and Advances | ₹11 Cr | ₹14 Cr | ₹11 Cr | ₹6.51 Cr | ₹9.45 Cr |
Advances recoverable in cash or in kind | ₹2.43 Cr | ₹5.83 Cr | ₹0.65 Cr | ₹0.62 Cr | ₹1.03 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹8.26 Cr | ₹8.20 Cr | ₹9.99 Cr | ₹5.89 Cr | ₹8.42 Cr |
Total Current Assets | ₹264 Cr | ₹207 Cr | ₹176 Cr | ₹126 Cr | ₹97 Cr |
Net Current Assets (Including Current Investments) | ₹161 Cr | ₹127 Cr | ₹96 Cr | ₹43 Cr | ₹19 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹419 Cr | ₹345 Cr | ₹303 Cr | ₹268 Cr | ₹248 Cr |
Contingent Liabilities | ₹5.54 Cr | ₹4.21 Cr | ₹4.92 Cr | ₹4.86 Cr | ₹6.33 Cr |
Total Debt | ₹0.01 Cr | ₹0.58 Cr | ₹1.37 Cr | ₹12 Cr | ₹37 Cr |
Book Value | 186.00 | 154.66 | 130.88 | 106.77 | 97.05 |
Adjusted Book Value | 186.00 | 154.66 | 130.88 | 106.77 | 97.05 |
Compare Balance Sheet of peers of RPG LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
RPG LIFE SCIENCES | ₹2,586.4 Cr | 2.9% | 3.6% | 91.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
RPG LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
RPG LIFE SCIENCES | 2.9% |
3.6% |
91.4% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses